Vonoprazan versus lansoprazole for healing and maintenance of healing of erosive esophagitis: a randomized trial

For decades, proton pump inhibitors (PPIs) have been the mainstay of treatment for erosive esophagitis. The potassium-competitive acid blocker vonoprazan provides more potent acid inhibition than PPIs but data on its efficacy for erosive esophagitis are limited.

Source: Gastroenterology - October 10, 2022 Category: Gastroenterology Authors: Loren Laine, Kenneth DeVault, Philip Katz, Stefan Mitev, John Lowe, Barbara Hunt, Stuart Spechler Tags: Clinical - Alimentary Tract Source Type: research